Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth ...
Abstract: During the twenty-first century, cardiovascular disease is a major global health consequence. Due to invisible illnesses such as cardiovascular diseases, human services consumption is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results